AstraZeneca
AZN
$68.88
Share price
0.22%
Change (1 day)
5.35%
Change (1 year)
Categories
Operating Margin for AstraZeneca (AZN)
Operating Margin as of March 2023 (TTM): -0.70%
According to AstraZeneca's latest financial reports and stock price the company's current Operating Margin is -0.70%. At the end of 2021 the company had an Operating Margin of -0.71%.
Operating Margin history for AstraZeneca from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -0.71% | -104.81% |
| 2020 | 14.71% | 131.75% |
| 2019 | 6.35% | -29.64% |
| 2018 | 9.02% | -8.99% |
| 2017 | 9.91% | -35.8% |
| 2016 | 15.44% | 24.32% |
| 2015 | 12.42% | 160.13% |
| 2014 | 4.77% | -62.42% |
| 2013 | 12.71% | -53.95% |
| 2012 | 27.59% | -25.06% |
| 2011 | 36.82% | 11.58% |
| 2010 | 32.99% | 0.15% |
| 2009 | 32.94% | 19.92% |
| 2008 | 27.47% | 1.72% |
| 2007 | 27.01% | -16.3% |
| 2006 | 32.27% | 15.92% |
| 2005 | 27.84% | 22.57% |
| 2004 | 22.71% | 2.43% |
| 2003 | 22.17% | -9.34% |
| 2002 | 24.45% | -1.16% |
| 2001 | 24.74% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 24.28% | -3,568.57% | 🇺🇸 USA |
 Novartis NVS | 16.15% | -2,407.14% | 🇨🇭 Switzerland |
 Pfizer PFE | 29.90% | -4,371.43% | 🇺🇸 USA |
 Abbott Laboratories ABT | 19.02% | -2,817.14% | 🇺🇸 USA |
 Eli Lilly LLY | 23.84% | -3,505.71% | 🇺🇸 USA |
 Sanofi SNY | 19.90% | -2,942.86% | 🇫🇷 France |
 Biogen BIIB | 35.30% | -5,142.86% | 🇺🇸 USA |
 Merck MRK | 28.49% | -4,170.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 16.70% | -2,485.71% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 19.52% | -2,888.57% | 🇬🇧 UK |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.